A protocol for the delivery of cannabidiol (CBD) and combined CBD and ∆(9)-tetrahydrocannabinol (THC) by vaporisation

BACKGROUND: Significant interest has emerged in the therapeutic and interactive effects of different cannabinoids. Cannabidiol (CBD) has been shown to have anxiolytic and antipsychotic effects with high doses administered orally. We report a series of studies conducted to determine the vaporisation...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:BMC Pharmacol Toxicol
Hlavní autoři: Solowij, Nadia, Broyd, Samantha J, van Hell, Hendrika H, Hazekamp, Arno
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2014
Témata:
Technical Advance
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4274767/
https://ncbi.nlm.nih.gov/pubmed/25319497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-6511-15-58
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky